KCT0007432招募中未知
An observational study to evaluate the safety and efficacy of MegaDerm®Soft in patients who underwent breast reconstruction using the MegaDerm soft.
Soon Chun Hyang University Hospital Bucheon0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 65(Year)(—)
- 性别
- All
入选标准
- •All subjects can participate in the clinical trial only when all of the following criteria are met.
- •? the patients who signed informed consent form
- •? Those aged 20 or over and under 65 years of age
- •? the patients who underwent breast reconstruction using Megaderm soft
排除标准
- •if any of the following items apply, the subject is excluded from the clinical trial.
- •? overweight (BMI =40 kg/m2)
- •? Other patients who were judged to be difficult to participate in this study by the investigator
研究者
相似试验
招募中
4 期
An observational study to evaluate the safety and efficacy of FOLFIRI / FOLFOX plus Cetuximab as first-line therapy inpatients with KRAS wild-type metastatic Colorectal cancerCTRI/2010/091/000161Merck Specialities Pvt Limited5th Floor , Shivsagar EstateDr. Annie Besant RoadMumbai 400018100
尚未招募
Unknown
An observational study to evaluate the safety and efficacy of lenvatinib plus pembrolizumab combination therapy for advanced or recurrent uterine cancer after use of platinum-based drugs(GOGO-EM4)JPRN-UMIN000049997Gynecologic Oncology Group of Osaka(GOGO)100
招募中
4 期
An Observational Study to evaluate the safety and efficacy of Cetuximab in combination with platinum-based chemotherapy, in the first-line therapy of recurrent/ metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)CTRI/2010/091/000170Merck Specialities Pvt Ltd5th Floor Shiv Sagar Estate, Dr. Aniie Besant Road, WorliMumbai 400018100
招募中
不适用
An observational study to investigate the safety and efficacy of niraparib for Japanese patients with recurrent ovarian cancer: maintenance therapy for platinum-sensitive recurrent treatment and monotherapy for late-line treatmentOvarian cancer, fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000046970Japanese Gynecologic Oncology Group180
已完成
不适用
An observational study to investigate the safety and efficacy of niraparib maintenance therapy after primary chemotherapy for Japanese patients with advanced ovarian, fallopian tube, or primary peritoneal cancerovarian cancer, fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000045931Japanese Gynecologic Oncology Group300
